Natera (NTRA) EBT Margin (2014 - 2026)
Natera's (NTRA) quarterly EBT Margin came in at 8.93% in Q2 2026, up 948.0% on a YoY basis from 0.85% in Q2 2025, and up 26.64% quarter-over-quarter from 12.17% in Q1 2026.
Powered by 
Analysis
Natera (NTRA) EBT Margin (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported EBT Margin for 13 consecutive years, with 8.93% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 948.0% year-over-year to 8.93%; the trailing twelve-month figure through Jun 2026 stood at 9.33% (up 357.0% YoY), and the FY2025 full-year result was 11.63%, down 44.0% from the prior year.
- EBT Margin advanced to 8.93% in Q2 2026 per NTRA's latest filing, from 12.17% in the prior quarter.
- Across five years, EBT Margin topped out at 2.0% in Q4 2025 and bottomed at 73.14% in Q2 2022.
- Historically, EBT Margin has averaged 30.41% across 5 years, with a median of 18.34% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 2947 bps in 2022, then jumped 4041 bps in 2023.
- Over 5 years, EBT Margin stood at 65.43% in 2022, then soared by 62 bps to 25.02% in 2023, then soared by 54 bps to 11.58% in 2024, then jumped by 83 bps to 2.0% in 2025, then plunged by 346 bps to 8.93% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 8.93%, 12.17%, and 2.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -8.93% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 13.54% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 10.36% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -35.81% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 2.30% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -0.23% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 24.29% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 6.87% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -22.65% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -0.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.93% |
| Mar 31, 2026 | -12.17% |
| Dec 31, 2025 | -2.00% |
| Sep 30, 2025 | -14.75% |
| Jun 30, 2025 | -18.42% |
| Mar 31, 2025 | -13.30% |
| Dec 31, 2024 | -11.58% |
| Sep 30, 2024 | -7.02% |
| Jun 30, 2024 | -8.85% |
| Mar 31, 2024 | -18.27% |
| Dec 31, 2023 | -25.02% |
| Sep 30, 2023 | -40.56% |
| Jun 30, 2023 | -42.50% |
| Mar 31, 2023 | -56.58% |
| Dec 31, 2022 | -65.43% |
| Sep 30, 2022 | -57.58% |
| Jun 30, 2022 | -73.14% |
| Mar 31, 2022 | -71.30% |
| Dec 31, 2021 | -81.26% |
| Sep 30, 2021 | -95.50% |